| 170.36 Net Asset Value | +0.41% 1 Day | +18.91% Year-to-Date | Overall Morningstar Rating |
| Health Style or Category | No Load Sales Expenses | 0.35% Expense Ratio | Low Morningstar Risk Rating™ |
| 1 month | +4.64% | 3 years | +19.82% | |
| 3 months | +13.64% | 5 years | +11.98% | |
| 1 year | +35.03% | Since inception | +16.73% |
| VGHCX | Category | |
|---|---|---|
| Performance 5-yr return | +11.98% | +12.10% |
| Expense ratio | 0.35% | 1.55% |
| Risk 5 year sharpe ratio | 0.79 | 0.71 |
| Net assets | $27.5B | $1.5B |
| Average market cap | $31.8B | $19.4B |
| Average P/E | 18.1 | 21.6 |
| Portfolio turnover | 8% | 8% |
There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.
| Fund family | Vanguard |
| Fund manager & tenure | Jean Hynes / 4 Years |
| Minimal initial investment | $3,000.00 |
| Minimum IRA investment | -- |
| Other | 100.00% |
| U.S. stock | -- |
| International stock | -- |
| Fixed income | -- |
| Cash | -- |
| Healthcare | 94.68% |
| Consumer service | 2.06% |
| Industrial materials | 1.68% |
| Consumer goods | 0.03% |
| Business service | 0.00% |
| MRK Merck & Co Inc | 6.02% |
| AMGN Amgen Inc | 4.47% |
| UNH UnitedHealth Group Inc | 4.17% |
| FRX Forest Laboratories, Inc. | 3.80% |
| -- Roche Holding AG | 3.68% |
| MCK McKesson, Inc. | 3.50% |
| PFE Pfizer Inc | 3.46% |
| LLY Eli Lilly and Company | 3.31% |
| -- Astellas Pharma, Inc. | 2.93% |
| -- AstraZeneca PLC | 2.85% |
.
